Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group

Martin S. Tallman, Haesook T. Kim, Pau Montesinos, Frederick R. Appelbaum, Javier De La Serna, John M. Bennett, Guillermo Deben, Clara D. Bloomfield, Jose Gonzalez, James H. Feusner, Marcos Gonzalez, Robert Gallagher, Jose D. Gonzalez-San Miguel, Richard A. Larson, Gustavo Milone, Elisabeth Paietta, Chelo Rayon, Jacob M. Rowe, Concha Rivas, Charles A. SchifferEdo Vellenga, Lois Shepherd, James L. Slack, Peter H. Wiernik, Cheryl L. Willman, Miguel A. Sanz

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds